Clinical Trial Update: An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome [Phase 3]

View source ↗

Summary

An extension Phase 3 trial evaluated long-term treatment with transdermal rotigotine for idiopathic restless legs syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED